Publications of Sascha Young Kupke

Hein, M., Chawla, A., Arora , P., Cattaneo, M., Winkler, M., Pöhlmann, S., Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Küchler, J., Püttker, S., Lahmann, P., Genzel, Y., Kupke, S. Y., Benndorf, D., & Reichl, U.Absolute quantification of viral proteins during single-round replication of MDCK suspension cellsPresented at: Proteomic Forum 2022Leipzig (Germany), April 3, 2022.

Kupke, S. Y., Hein, M. D., Bdeir, N., Rand, U., Marichal-Gallardo, P., Cicin-Sain, L., Bruder, D., Pöhlmann, S., Schughart, K., & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: 31st Annual Meeting of the Society for Virologyonline, March 30, 2022.

Kupke, S. Y., Hein, M., Bdeir, N., Rand, U., Marichal-Gallardo, P., Cicin-Sain, L., Bruder, D., Pöhlmann, S., Schughart, K., & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral CandidatesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidatesPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Pelz, L., Rüdiger, D., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-continuous propagation of influenza A virus and its defective interfering particles - analyzing the dynamic competition to select antiviral candidatesPresented at: 30th Annual Meeting of the Society for Virologyonline, March 24, 2021.

Kupke, S. Y., Hein, M. D., Kollmus, H., Marichal-Gallardo, P., Schughart, K., & Reichl, U.The novel influenza A virus defective interfering particle "OP7" as an antiviral agent: discovery, production, and animal trialsPresented at: The seventh ESWI Influenza ConferenceVirtual Meeting, December 6, 2020.

Kupke, S. Y., Riedel, D., Frensing, T., Zmora, P., & Reichl, U.A novel type of defective interfering particle for antiviral therapyPresented at: 26th ESACT MeetingCopenhagen, Denmark, May 5, 2019.

Rüdiger, D., Laske, T., Kupke, S. Y., & Reichl, U.A multiscale model of defective interfering particle replicationPresented at: FOSBE 2019Valencia, Spain, October 15, 2019.

Rüdiger, D., Kupke, S. Y., & Reichl, U.A multiscale model of influenza A virus replication covering highly different infection conditions in cell culturesPresented at: Foundations of Systems Biology in Engineering - 7th FOSBE 2018Oak Brook, Illinois, USA, August 5, 2018.

Rüdiger, D., Heldt, S., Kupke, S. Y., & Reichl, U.Stochastic multiscale modeling of influenza virus production in cell cultures. Poster presented at 6th IFAC Conference on Foundations of Systems Biology in EngineeringPresented at: 6th IFAC Conference on Foundations of Systems Biology in Engineering (FOSBE)Magdeburg, Germany, October 9, 2016.

Rüdiger, D., Heldt, S., Kupke, S. Y., & Reichl, U.Stochastic multiscale modeling of influenza virus production in cell culturesPresented at: 6th IFAC Conference on Foundations of Systems Biology in Engineering (FOSBE)Magdeburg, Germany, October 9, 2016.

Kupke, S. Y., Heldt, F. S., Frensing, T., & Reichl, U.Single Cell Analysis of Influenza A Virus-infected Cells for the Optimization of Cell Culture-based Vaccine Manufacturing ProcessesPresented at: ESACT 2015Barcelona, Spain, May 31, 2015.

Kupke, S. Y. (2020)Single-cell analysis of influenza A virus replication: sources of cell-to-cell heterogeneity and discoverey of a novel type of defective interfering particlePhD Thesis, Otto-von-Guericke-Universität, Magdeburgdoi: 10.25673/32916.

Kupke, S. Y., Frensing, T., Zmora, P., & Reichl, U. (2020)Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use.

Pelz, L., Rüdiger, D., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U. (2021)Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapybioRxivdoi: 10.1101/2021.02.08.430251 .